Q2 2019 Holdings
Filed 2019-08-08 | 14 holdings | $107.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2019-08-13) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BridgeBio (Bbio)(BBIO) | COM | 10806X102 | $103.4M | 3,835,722 | 96.1% |
| Arcus Biosciences, Inc. (Rcus)(RCUS) | COM | 03969F109 | $2.7M | 333,333 | 2.5% |
| Aclaris Theraputics Inc (Acrs)(ACRS) | COM | 00461U105 | $1.4M | 634,455 | 1.3% |
| Eidos Therapeutics, Inc. (Eidix)(EIDXGBP) | COM | 28249H104 | $34.9K | 1,123,630 | 0.0% |
| Marker Therapeutics, Inc. (Mrkr) | COM | 57055L107 | $15.8K | 2,000,000 | 0.0% |
| ObsEva SA (Obsv) | COM | H5861P103 | $15.7K | 1,386,338 | 0.0% |
| Avrobio, Inc. (Avro) | COM | 05455M100 | $13.2K | 811,998 | 0.0% |
| Biohaven Pharmaceutical Holding Company Ltd. (Bhvn)(BHVN) | COM | G11196105 | $12.0K | 274,513 | 0.0% |
| Aeglea Biotherapeutics Inc (Agle)(AGLEUSD) | COM | 00773J103 | $8.8K | 1,291,151 | 0.0% |
| Atreca (Bcel)(BCELUSD) | CL A COM | 04965G109 | $7.3K | 387,653 | 0.0% |
| Zosano Pharma Corporation (Zsan)A | COM | 98979H202 | $6.6K | 2,028,571 | 0.0% |
| Sunesis Pharmaceuticals, Inc. (Snss) | COM | 867328700 | $5.5K | 7,600,000 | 0.0% |
| Nabriva Therapeutics plc (Nbrv) | SHS | G63637105 | $4.4K | 1,809,259 | 0.0% |
| Verona Pharma plc (Vrna)(VRNA) | COM | 925050106 | $2.3K | 443,596 | 0.0% |